An article in Cardiology News describes the effort to bring regenerative medicine into clinical practice for cardiovascular disease. Although routine stem cell applications for cardiovascular disease are not yet available, current research spans the spectrum of heart diseases, deepening our knowledge base. This new knowledge is translating into a regenerative medicine care that moves towards prevention, protection, and repair and away from fighting disease.
The article builds on a presentation delivered by Andre Terzic M.D., Ph.D., director of Mayo Clinic’s Center for Regenerative Medicine at the 2016 American Heart Association Scientific Sessions 2016 in New Orleans.
Read the article on Cardiology News: Regenerative medicine is likely game changer for cardiovascular disease.
Read more about the Mayo Clinic Center for Regenerative Medicine Cardiac Regeneration Program.